October 26, 2022
FDA: Class I recall of Jiangsu Well Biotech COVID-19 Ag Rapid Test
Editor's Note
The Food and Drug Administration (FDA) on October 12 identified the recall of Jiangsu Well Biotech’s COVID-19 Ag Rapid Test Devices as Class I, the most serious.
The recall was initiated because the tests were distributed to US customers without authorization, clearance, or approval from the FDA.
No complaints, injuries, or deaths have been reported.
Distribution dates were July 23, 2021 to January 23, 2022.
Free Daily News
- Acknowledging burnout can open discussion for improvement
- Mechanism found to boost muscle injury repair
- Federal program solicits autonomous robotic surgery technology proposals
- Financial hardships a reality for some after surgery
- Marburg virus disease outbreak in Ethiopia sparks alert for readiness in US
- OR Manager Welcomes New Content Director Joe Paone to Lead Brand Into Its Next Chapter
- Health access concerns up
- AI wound care monitor detects infections early
- Leaders need to build human-centered skills
- Trends in US outpatient surgery growth
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement